Project Grant W81XWH2210703
Award Date
8/1/22
Completion Date
7/31/26
Dollars Obligated
$797K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Switzerland
Similar Awards
The Department of the Army Medical Command awarded a $1,304,470.00 Project Grant to Yale University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the grant is to support the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER". The award commenced on July 1, 2025 and is scheduled for completion on June 30, 2029. The Military Medical Research and Development program funds advanced...
The Department of the Army Medical Command awarded a $438,916 project grant to Universitat Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to target PARP inhibitor resistance. Through this funding, Universitat Bern researchers will investigate medical solutions for targeting resistance to poly (ADP-ribose) polymerase inhibitors, an area of focus under the Military Medical...
The Department of the Army Medical Command awarded a $954,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Massachusetts Institute of Technology (MIT) for the project "TUMOR-TARGETED NANOCARRIERS FOR EFFECTIVE IMMUNOMODULATION OF OVARIAN CANCER". The grant, effective from May 1, 2025 to April 30, 2028, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The...
The U.S. Department of the Army's Military Medical Research and Development program (CFDA 12.420) awarded a $577,680 Project Grant to The Regents of the University of Colorado to conduct research on "Targeting EHMT1/2 to Overcome Therapy-Resistant Ovarian Cancer". The award, effective May 1, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the public. The research aims to advance disease prevention, diagnosis, treatment,...
The Universite De Geneve will receive $439,332 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research targeting PARP inhibitor resistance from September 1, 2022 to August 31, 2026. Through this four-year Project Grant, the Universite De Geneve will investigate medical solutions for the battlefield by exploring ways to overcome resistance to poly (ADP-ribose) polymerase inhibitors, which are a class of targeted...
The Department of the Army Medical Command awarded a $466,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Washington University in University City, Missouri. The grant, titled "Leveraging the Ovarian Tumor Microenvironment for Early Detection Strategies", will fund research focused on transforming healthcare for military service members and the broader public through advanced biomedical investigations. The award period runs from August...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $1,004,472.00 to Yale University to conduct advanced biomedical research focused on mast cell therapy for ovarian cancer. The award, effective June 15, 2025 through June 14, 2029, supports Yale's efforts to transform healthcare for military service members and the broader public through innovative and impactful research. The university's expertise...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,997 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to dissect ovarian cancer tumor-immune microenvironments through 3D in situ molecular profiling from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
This Project Grant award of $469,381 from the U.S. Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Leland Stanford Junior University (Stanford University) to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors using metabolite-sensing receptors. The 2-year award, effective from April 15, 2025 to April 14, 2027, aims to advance disease prevention, diagnosis, treatment, and management of...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,130,469 to Yale University to uncover the tumor-immune microenvironmental determinants of immunotherapy response in renal cell carcinoma through ex vivo patient-derived models. The research aims to transform health care for Service Members and the American public through innovative and impactful research investigating medical solutions for the battlefield....